State AZ
Clinical Trials in Arizona
Recruiting clinical trials with at least one study location in Arizona. Data updated daily from ClinicalTrials.gov.
Top Conditions in Arizona
NCT06418204 N/A
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...
Condition
Breast Carcinoma
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
NCT05919511 N/A
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Condition
cGVHD
Enrollment
1,500 pts
Location
United States
Sponsor
Incyte Corporation
NCT06991114 Phase 2
Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Ther...
Condition
Refractory Rheumatoid Arthritis (RA)
Enrollment
90 pts
Location
United States, Bulgaria, France
Sponsor
Artiva Biotherapeutics, Inc.
NCT06544499 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participan...
Condition
Primary Immune Thrombocytopenia (ITP)
Enrollment
69 pts
Location
United States, Austria, Bulgaria
Sponsor
argenx
NCT05787587 Phase 1
Recruiting
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Condition
Advanced or Metastatic Solid Tumors
Enrollment
216 pts
Location
United States
Sponsor
IDEAYA Biosciences
NCT07216521 N/A
Recruiting
Intent of Surgery for IPMN
Condition
Intraductal Papillary Mucinous Neoplasm
Enrollment
2,000 pts
Location
United States, China, Germany
Sponsor
NYU Langone Health
NCT05006716 Phase 1, Phase 2
Recruiting
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell M...
Condition
B-cell Malignancy
Enrollment
614 pts
Location
United States, Australia, Brazil
Sponsor
BeOne Medicines
NCT06808984 Phase 2
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the ...
Condition
Agitation
Enrollment
120 pts
Location
United States
Sponsor
Celgene
NCT06079671 Phase 3
Recruiting
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (e...
Condition
Locally Advanced Cervical Cancer
Enrollment
800 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
NCT06806592 Phase 3
Recruiting
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to ...
Condition
Interstitial Lung Diseases
Enrollment
400 pts
Location
United States, Australia, Austria
Sponsor
Boehringer Ingelheim
NCT02402244 N/A
Recruiting
Project: Every Child for Younger Patients With Cancer
Condition
Adrenal Gland Pheochromocytoma
Enrollment
75,000 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT05846802 N/A
Recruiting
Gastroparesis Registry 4
Condition
Gastroparesis
Enrollment
250 pts
Location
United States
Sponsor
Johns Hopkins Bloomberg School
NCT06937229 Phase 3
Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agi...
Condition
Alzheimer Disease
Enrollment
600 pts
Location
United States, Argentina, Brazil
Sponsor
Bristol-Myers Squibb
NCT06106672 Phase 1, Phase 2
Recruiting
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in S...
Condition
Myasthenia Gravis
Enrollment
54 pts
Location
United States
Sponsor
COUR Pharmaceutical Developmen
NCT06792695 Phase 2
Recruiting
A Study of Novel Study Interventions and Combinations in Participants With Color...
Condition
Metastatic Colorectal Cancer
Enrollment
120 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT04930653 Phase 2
Recruiting
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermi...
Condition
Folliculotropic Mycosis Fungoides
Enrollment
34 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT06513962 Phase 3
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
60 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT07284186 Phase 1
Recruiting
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Condition
Esophageal Squamous Cell Carcinoma
Enrollment
155 pts
Location
United States
Sponsor
Plexium, Inc.
NCT06307652 Phase 3
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Hear...
Condition
Heart Failure and Impaired Kidney Function
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06803589 EARLY_Phase 1
Recruiting
Growth Hormone for the Treatment of Gastroparesis
Condition
Gastroparesis
Enrollment
10 pts
Location
United States
Sponsor
Mayo Clinic
NCT07276997 Phase 2
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcapr...
Condition
Major Depressive Disorder
Enrollment
195 pts
Location
United States
Sponsor
AbbVie
NCT05889624 N/A
Recruiting
Responding With Evidence and Access for Childhood Headaches
Condition
Headache
Enrollment
400 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT05919680 Phase 2
Recruiting
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease...
Condition
Intestinal Failure Associated Liver Disease
Enrollment
36 pts
Location
United States
Sponsor
NorthSea Therapeutics B.V.
NCT06158880 N/A
Recruiting
Alcohol & Men's Sexual Risk Behaviors
Condition
Sexual Behavior
Enrollment
320 pts
Location
United States
Sponsor
Arizona State University
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
Page 1 of 11 — 256 trials total